Human bite antibiotic prophylaxis
Reading File
Finding Sources
Searching PubMed
human bite wound antibiotic prophylaxis
Reading File
Reading File
Reading File
Reading File
Reading File
Excellent - I now have comprehensive, authoritative data from multiple textbooks. Here is the full answer:
Human Bite - Antibiotic Prophylaxis
Why Human Bites are High-Risk
Human bites carry a higher infection risk than most animal bites because the oral cavity harbors a dense, polymicrobial flora including both aerobes and anaerobes. Infection rates for untreated human bite wounds can exceed 15-20%. Prophylaxis is indicated for all human bites - unlike dog bites where it is only "sometimes" used, Harrison's explicitly lists prophylaxis for human bites as "Always".
Key Pathogens
| Organism | Notes |
|---|---|
| Viridans streptococci | Most common overall |
| Staphylococcus aureus | Including potential MRSA in high-risk patients |
| Eikenella corrodens | Gram-negative anaerobic rod, characteristic of human bites; resistant to clindamycin alone |
| Haemophilus influenzae | Particularly relevant in occlusional bites |
| Oral anaerobes | Beta-lactamase-positive species common |
Antibiotic Regimens
First-line (No Penicillin Allergy)
Amoxicillin-clavulanate (co-amoxiclav)
- Adult dose: 875/125 mg PO q12h (oral) or ampicillin-sulbactam 3.0 g IV q6h (inpatient/severe)
- Duration: 5-7 days for prophylaxis; up to 14 days for established infection
- Covers: streptococci, S. aureus, H. influenzae, beta-lactamase-positive anaerobes, and Eikenella corrodens
Penicillin-Allergic Patients
| Severity of Allergy | Regimen |
|---|---|
| Non-anaphylactic (cephalosporins safe) | Ceftriaxone + metronidazole |
| Anaphylactic/IgE-mediated | Clindamycin or metronidazole plus TMP-SMX (1 DS tablet PO bid) or ciprofloxacin (500 mg PO bid) |
| Single-agent alternative | Moxifloxacin (fluoroquinolone with anaerobic coverage) |
Note: Clindamycin alone should not be used for human bites - it lacks activity against Eikenella corrodens and gram-negatives like H. influenzae.
MRSA Consideration
Empirical MRSA-active therapy (vancomycin IV, or add TMP-SMX to cover MRSA) should be considered in high-risk situations (immunocompromised, previous MRSA, healthcare worker, IV drug user) while cultures are pending.
When Prophylaxis is Especially Indicated
Any human bite qualifies, but the following increase urgency (Harriet Lane, Miller's Orthopaedics):
- Bites to the hand, foot, face, or genitalia
- Puncture wounds or crush injuries (hard to irrigate)
- Bites near/over joints, tendons, cartilage, or bone
- Immunocompromised or asplenic hosts
- Delayed presentation (≥12 hours on extremities, ≥24 hours on face)
- Lacerations closed primarily
Special Scenario: "Fight Bite" (Clenched-Fist Injury)
When a person's knuckle strikes another person's teeth, the resulting wound is a human bite over the metacarpophalangeal joint. This is a surgical emergency - the bite penetrates the joint capsule and inoculates the joint space during flexion, sealing bacteria in on extension. Requires:
- X-ray (look for cartilage defects, broken tooth fragments, fractures)
- Surgical exploration and washout
- IV antibiotics (ampicillin-sulbactam or equivalent)
Wound Management Alongside Antibiotics
- Copious irrigation under pressure
- Debridement of devitalized tissue
- Do not close primarily (except facial wounds, if <24 hours old and clinically uninfected)
- Tetanus prophylaxis - assess immunization status
- HIV/HBV/HCV: assess source patient's status; post-exposure prophylaxis considerations apply in occupational or known high-risk bites
Duration
- Prophylaxis: 5 days
- Established infection: 5-14 days; longer if osteomyelitis or septic arthritis develops
Sources:
- Harrison's Principles of Internal Medicine 22E, Table 146-1 - Management of Wound Infections Following Animal and Human Bites
- Harriet Lane Handbook 23E (Johns Hopkins), Table 2.4 - Antibiotic Management of Animal and Human Bites
- Miller's Review of Orthopaedics 9E, Table 1.28 - Soft Tissue Infections
- Textbook of Family Medicine 9E - prophylactic antibiotics reduce infection incidence (SOR: C)
Clindamycin dose for human bite
Finding Sources
Reading File
Reading File
Here are the clindamycin doses for human bite, pulled directly from the textbooks:
Clindamycin for Human Bite - Dosing
Clindamycin is a second-line agent in penicillin-allergic patients. It must always be combined with a second drug (TMP-SMX or a fluoroquinolone) because it has no activity against Eikenella corrodens or gram-negatives like H. influenzae.
Adults
| Route | Dose | Frequency | Duration |
|---|---|---|---|
| PO (oral) | 300-450 mg | q6-8h | 5 days (prophylaxis) / 5-14 days (infection) |
| IV (severe infection) | 600 mg | q8h | Until clinically improved, then step down to oral |
Paired with (choose one):
- TMP-SMX 1 DS tablet (160/800 mg) PO bid, or
- Ciprofloxacin 500 mg PO bid
The first dose should ideally be given within 3-4 hours of injury. - Rosen's Emergency Medicine
Paediatrics (weight <40 kg)
| Route | Dose | Notes |
|---|---|---|
| IV (first dose) | 5-10 mg/kg IV (max 600 mg) | Given as first dose for hand/joint wounds |
| PO (subsequent) | 10-30 mg/kg/day divided q6-8h |
Paired with: TMP-SMX 8-10 mg/kg/day of trimethoprim component divided q12h, for 3-5 days. - Pfenninger & Fowler's Procedures for Primary Care
Important Caveats
- Do not use clindamycin alone - it covers gram-positives and anaerobes but misses Eikenella corrodens, which is the hallmark pathogen of human bites
- Clindamycin carries a risk of C. difficile colitis - mention this when prescribing
- If the patient has a non-anaphylactic penicillin allergy (not IgE-mediated), a cephalosporin (e.g. ceftriaxone IV) + metronidazole is often preferable and simpler
- For hand/fight-bite wounds, the threshold for IV antibiotics and admission is low regardless of the regimen chosen
This is a shared conversation. Sign in to Orris to start your own chat.